Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2124223 | European Journal of Cancer | 2009 | 8 Pages |
Abstract
The future of cervical cancer control may become a diversified strategy, one for non-vaccinated birth cohorts and another for vaccinated cohorts. It will take another 50 years before the non-vaccinated cohorts have passed the screening age. With the current uncertainty concerning the long term protection from HPV-vaccination it will furthermore be precautionary to continue screening practice for the first cohorts of HPV-vaccinated women. Organised vaccination and screening programmes with good record keeping are necessary to optimise the future control of cervical cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Elsebeth Lynge, Ahti Antilla, Marc Arbyn, Nereo Segnan, Guglielmo Ronco,